There is a long history of medical interventions designed to help people control their weight, none of which have halted the rise in obesity
Unfortunately, the information and studies we have on these medications are limited at this time, but its already very clear that using a weight loss medication like compounded GLP-1 can offer many benefits, far beyond weight loss
Published research has examined its effects on melanogenesis, UV-induced DNA damage, and melanocyte proliferation in various experimental systems
Broader clinical effects influence prescribing decisions, as some analyses report a 25% reduction in cardiovascular risk among people using semaglutide, which informs benefit-risk assessments beyond weight alone
The clinician wanted to admit a patient with anorexia who was taking a GLP-1 drug, despite having an extremely low body mass index (BMI) of 16 the equivalent of a 5-foot-3 person who weighs 90 pounds